临床试验方案与报告中结局报告推荐意见:范围综述
该范围综述检索近10年文献,从244份合格文件中提取1758条结局报告推荐意见,与70条候选条目比较后新增62条,形成132条候选条目。现有推荐意见来源分散、异质性大,SPIRIT-Outcomes与CONSORT-OUTCOMES扩展正在开发以促进结局报告规范化。
要点
- 现有临床试验结局报告推荐意见分散且异质性大,难以获取和实践应用。
- 综述从244份文件中提取1758条推荐意见,经比较形成132条候选条目。
- 正在开发的SPIRIT-Outcomes和CONSORT-Outcomes扩展可能有助于规范结局报告。
核心结论
- 临床试验方案与报告的结局报告指导缺乏一致性,且分散在大量来源中,实践中可能难以获取和实施。
研究设计与样本
- 范围综述,检索MEDLINE和Cochrane方法学注册库,并进行灰色文献检索和滚雪球式补充,纳入近10年发布的244份合格文件。
- 两名评价者经培训后独立完成标题摘要筛选、全文筛选和数据提取。
主要发现
- 共从244份合格文件中识别1758条试验结局报告推荐意见,其中72%的文件由学术期刊发布。
- 将每条推荐意见与初始70条候选条目比较后,新增62条,形成132条候选条目。
- 候选条目涵盖结局选择、定义、测量、分析、解释及试验文件间修改的报告。
- 每个候选条目对应的支持文件数量差异很大(中位数5,范围0-84份文件/条目)。
临床怎么用
- 作者在撰写试验方案和报告时,可参考SPIRIT-OUTCOMES和CONSORT-OUTCOMES扩展(正在开发中)以更透明完整地描述结局。
局限性
- 现有结局报告指导缺乏一致性且来源分散,可能难以获取和实践应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinicians, patients, and policy-makers rely on published evidence from clinical trials to help inform decision-making. A lack of complete and transparent reporting of the investigated trial outcomes limits reproducibility of results and knowledge synthesis efforts, and contributes to outcome switching and other reporting biases. Outcome-specific extensions for the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT-Outcomes) and Consolidated Standards of Reporting Trials (CONSORT-Outcomes) reporting guidelines are under development to facilitate harmonized reporting of outcomes in trial protocols and reports. The aim of this review was to identify and synthesize existing guidance for trial outcome reporting to inform extension development. METHODS: We searched for documents published in the last 10 years that provided guidance on trial outcome reporting using: an electronic bibliographic database search (MEDLINE and the Cochrane Methodology Register); a grey literature search; and solicitation of colleagues using a snowballing approach. Two reviewers completed title and abstract screening, full-text screening, and data charting after training. Extracted trial outcome reporting guidance was compared with candidate reporting items to support, refute, or refine the items and to assess the need for the development of additional items. RESULTS: In total, 1758 trial outcome reporting recommendations were identified within 244 eligible documents. The majority of documents were published by academic journals (72%). Comparison of each recommendation with the initial list of 70 candidate items led to the development of an additional 62 items, producing 132 candidate items. The items encompassed outcome selection, definition, measurement, analysis, interpretation, and reporting of modifications between trial documents. The total number of documents supporting each candidate item ranged widely (median 5, range 0-84 documents per item), illustrating heterogeneity in the recommendations currently available for outcome reporting across a large and diverse sample of sources. CONCLUSIONS: Outcome reporting guidance for clinical trial protocols and reports lacks consistency and is spread across a large number of sources that may be challenging to access and implement in practice. Evidence and consensus-based guidance, currently in development (SPIRIT-Outcomes and CONSORT-Outcomes), may help authors adequately describe trial outcomes in protocols and reports transparently and completely to help reduce avoidable research waste.
引用
- Butcher NJ, Mew EJ, Monsour A, et al. Outcome reporting recommendations for clinical trial protocols and reports: a scoping review. Trials. 2020. PMID: 32641085. doi:10.1186/s13063-020-04440-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。